{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:20:36Z","timestamp":1791058836665,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T00:00:00Z","timestamp":1441152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00436-015-4684-8","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T06:02:22Z","timestamp":1441087342000},"page":"4431-4439","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Assessment of blood\u2013brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain"],"prefix":"10.1007","volume":"114","author":[{"given":"Sharon L.","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane T.","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemaria","family":"Gennuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny","family":"Kofos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama R.","family":"Sriram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P. C.","family":"Dorlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Qvarnstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Kucerova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Joseph","family":"Guglielmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govinda S.","family":"Visvesvara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,2]]},"reference":[{"key":"4684_CR1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1550-7408.2011.00541.x","volume":"58","author":"AF Ahmad","year":"2011","unstructured":"Ahmad AF, Andrews PW, Kilvington S (2011) Development of a nested PCR for environmental detection of the pathogenic free-living amoeba Balamuthia mandrillaris. J Eukaryot Microbiol 58:269\u2013271. doi: 10.1111\/j.1550-7408.2011.00541.x","journal-title":"J Eukaryot Microbiol"},{"key":"4684_CR2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4269\/ajtmh.2003.68.65","volume":"68","author":"GC Booton","year":"2003","unstructured":"Booton GC, Carmichael JR, Visvesvara GS, Byers TJ, Fuerst P (2003a) Genotyping of Balamuthia mandrillaris based on nuclear 18S and mitochondrial 16S rRNA genes. Am J Trop Med Hyg 68:65\u201369","journal-title":"Am J Trop Med Hyg"},{"key":"4684_CR3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1128\/JCM.41.1.453-455.2003","volume":"41","author":"GC Booton","year":"2003","unstructured":"Booton GC, Carmichael JR, Visvesvara GS, Byers TJ, Fuerst PA (2003b) Identification of Balamuthia mandrillaris by PCR assay using the mitochondrial 16S rRNA gene as a target. J Clin Microbiol 41:453\u2013455","journal-title":"J Clin Microbiol"},{"key":"4684_CR4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/QCO.0b013e3283428d1e","volume":"24","author":"FG Bravo","year":"2011","unstructured":"Bravo FG, Alvarez PJ, Gotuzzo E (2011) Balamuthia mandrillaris infection of the skin and central nervous system: an emerging disease of concern to many specialties in medicine. Curr Opin Infect Dis 24:112\u2013117. doi: 10.1097\/QCO.0b013e3283428d1e","journal-title":"Curr Opin Infect Dis"},{"key":"4684_CR5","doi-asserted-by":"crossref","first-page":"e699","DOI":"10.1542\/peds.2009-1797","volume":"125","author":"LC Cary","year":"2010","unstructured":"Cary LC, Maul E, Potter C, Wong P, Nelson PT, Given C 2nd, Robertson W Jr (2010) Balamuthia mandrillaris meningoencephalitis: survival of a pediatric patient. Pediatrics 125:e699\u2013e703. doi: 10.1542\/peds.2009-1797","journal-title":"Pediatrics"},{"key":"4684_CR6","first-page":"1165","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","unstructured":"Centers for Disease Control and Prevention (2010) Balamuthia mandrillaris transmitted through organ transplantation\u2014Mississippi, 2009. MMWR Morb Mortal Wkly Rep 59:1165\u20131170","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4684_CR7","first-page":"666","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","unstructured":"Centers for Disease Control and Prevention (2013) Investigational drug available directly from CDC for the treatment of infections with free-living amebae. MMWR Morb Mortal Wkly Rep 62:666","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4684_CR8","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1086\/379020","volume":"37","author":"TR Deetz","year":"2003","unstructured":"Deetz TR, Sawyer MH, Billman G, Schuster FL, Visvesvara GS (2003) Successful treatment of Balamuthia amoebic encephalitis: presentation of two cases. Clin Infect Dis 37:1304\u20131312","journal-title":"Clin Infect Dis"},{"key":"4684_CR9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jchromb.2008.02.005","volume":"865","author":"TPC Dorlo","year":"2008","unstructured":"Dorlo TPC, Hillebrand MJX, Rosing H, Eggelte TA, de Vries PJ, Beijnen JH (2008a) Development and validation of a quantitative assay for the measurement of miltefosine in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 865:55\u201362. doi: 10.1016\/j.jchromb.2008.02.005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"4684_CR10","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.00014-08","volume":"52","author":"TP Dorlo","year":"2008","unstructured":"Dorlo TP, van Thiel PP, Huitema AD, Keizer RJ, de Vries HJ, Beijnen JH, de Vries PJ (2008b) Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients. Antimicrob Agents Chemother 52:2855\u20132860. doi: 10.1128\/AAC.00014-08","journal-title":"Antimicrob Agents Chemother"},{"key":"4684_CR11","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","volume":"67","author":"TP Dorlo","year":"2012","unstructured":"Dorlo TP, Balasegaram M, Beijnen JH, de Vries PJ (2012a) Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis. J Antimicrob Chemother 67:2576\u20132597. doi: 10.1093\/jac\/dks275","journal-title":"J Antimicrob Chemother"},{"key":"4684_CR12","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1128\/AAC.00292-12","volume":"56","author":"TP Dorlo","year":"2012","unstructured":"Dorlo TP, Huitema AD, Beijnen JH, de Vries PJ (2012b) Optimal dosing of miltefosine in children and adults with visceral leishmaniasis. Antimicrob Agents Chemother 56:3864\u20133872. doi: 10.1128\/AAC.00292-12","journal-title":"Antimicrob Agents Chemother"},{"key":"4684_CR13","unstructured":"Food and Drug Administration (2015) Impavido\/Miltefosine\u2014label and approval history. In: Drugs@FDA. http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.Label_ApprovalHistory#apphist . Accessed 01 July 2015."},{"key":"4684_CR14","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1099\/mic.0.27218-0","volume":"150","author":"TH Dunnebacke","year":"2004","unstructured":"Dunnebacke TH, Schuster FL, Yagi S, Booton GC (2004) Balamuthia mandrillaris from soil samples. Microbiology 150:2837\u20132842","journal-title":"Microbiology"},{"key":"4684_CR15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0305-7372(90)90053-I","volume":"17","author":"H Eibl","year":"1990","unstructured":"Eibl H, Unger C (1990) Hexadecylphosphocholine: a new and selective antitumor drug. Cancer Treat Rev 17:233\u2013242","journal-title":"Cancer Treat Rev"},{"key":"4684_CR16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00436-006-0302-0","volume":"100","author":"PJ Finnin","year":"2007","unstructured":"Finnin PJ, Visvesvara GS, Campbell BE, Fry DR, Gasser RB (2007) Multifocal Balamuthia mandrillaris infection in a dog in Australia. Parasitol Res 100:423\u2013426","journal-title":"Parasitol Res"},{"key":"4684_CR17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1354\/vp.41-5-506","volume":"41","author":"O Foreman","year":"2004","unstructured":"Foreman O, Sykes J, Ball L, Yang N, De Cock H (2004) Disseminated infection with Balamuthia mandrillaris in a dog. Vet Pathol 41:506\u2013510","journal-title":"Vet Pathol"},{"key":"4684_CR18","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1086\/314731","volume":"179","author":"ZH Huang","year":"1999","unstructured":"Huang ZH, Ferrante A, Carter RF (1999) Serum antibodies to Balamuthia mandrillaris, a free-living amoeba recently demonstrated to cause granulomatous amoebic encephalitis. J Infect Dis 179:1305\u20131208","journal-title":"J Infect Dis"},{"key":"4684_CR19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/AAC.40.3.825","volume":"40","author":"S Jaruratanasirikul","year":"1996","unstructured":"Jaruratanasirikul S, Hortiwakul R, Tantisarasart T, Phuenpathom N, Tussanasunthornwong S (1996) Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye. Antimicrob Agents Chemother 40:825\u2013826","journal-title":"Antimicrob Agents Chemother"},{"key":"4684_CR20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.5858\/2004-128-466-BMMIAI","volume":"128","author":"S Jung","year":"2004","unstructured":"Jung S, Schelper RL, Visvesvara GS, Chang HT (2004) Balamuthia mandrillaris meningoencephalitis in an immunocompetent patient: an unusual clinical course and a favorable outcome. Arch Pathol Lab Med 128:466\u2013468","journal-title":"Arch Pathol Lab Med"},{"key":"4684_CR21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00436-008-1243-6","volume":"104","author":"AF Kiderlen","year":"2009","unstructured":"Kiderlen AF, Radam E, Tata PS (2009) Assessment of Balamuthia mandrillaris-specific serum antibody by flow cytometry. Parasitol Res 104:663\u2013670. doi: 10.1007\/s00436-008-1243-6","journal-title":"Parasitol Res"},{"key":"4684_CR22","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1128\/CVI.05082-11","volume":"18","author":"Z Kucerova","year":"2011","unstructured":"Kucerova Z, Sriram R, Wilkins PP, Visvesvara GS (2011) Identification of antigenic targets for immunodetection of Balamuthia mandrillaris. Clin Vaccine Immunol 18:1297\u20131301. doi: 10.1128\/CVI.05082-11","journal-title":"Clin Vaccine Immunol"},{"key":"4684_CR23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF00695989","volume":"31","author":"M Marschner","year":"1992","unstructured":"Marschner M, K\u00f6tting J, Eibl H, Unger C (1992) Distribution of hexadecylphosphocholine and octadecyl-methyl-glycero-3-phosphocholine in rat tissues during steady-state treatment. Cancer Chemother Pharmacol 31:18\u201322","journal-title":"Cancer Chemother Pharmacol"},{"key":"4684_CR24","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1086\/653609","volume":"51","author":"DY Mart\u00ednez","year":"2010","unstructured":"Mart\u00ednez DY, Seas C, Bravo C, Legua P, Ramos C, Cabello AM, Gotuzzo E (2010) Successful treatment of Balamuthia mandrillaris amoebic infection with extensive neurological and cutaneous involvement. Clin Infect Dis 51:e7\u2013e11. doi: 10.1086\/653609","journal-title":"Clin Infect Dis"},{"key":"4684_CR25","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","volume":"23","author":"R Nau","year":"2010","unstructured":"Nau R, S\u00f6rgel F, Eiffert H (2010) Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections. Clin Microbiol Rev 23:858\u2013883. doi: 10.1128\/CMR.00007-10","journal-title":"Clin Microbiol Rev"},{"key":"4684_CR26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00436-009-1592-9","volume":"106","author":"M Niyyati","year":"2009","unstructured":"Niyyati M, Lorenzo-Morales J, Rezaeian M, Martin-Navarro CM, Haghi AM, Maciver SK, Valladares B (2009) Isolation of Balamuthia mandrillaris from urban dust, free of known infectious involvement. Parasitol Res 106:279\u2013281. doi: 10.1007\/s00436-009-1592-9","journal-title":"Parasitol Res"},{"key":"4684_CR27","doi-asserted-by":"crossref","unstructured":"Petersen CA, Greenlee MHW (2011) Neurologic manifestations of Leishmania spp. infection. J Neuroparasitology 2: doi: 10.4303\/jnp\/N110401","DOI":"10.4303\/jnp\/N110401"},{"key":"4684_CR28","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1128\/JCM.00875-06","volume":"44","author":"Y Qvarnstrom","year":"2006","unstructured":"Qvarnstrom Y, Visvesvara GS, Sriram R, da Silva AJ (2006) Multiplex real-time PCR assay for simultaneous detection of Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri. J Clin Microbiol 44:3589\u20133595","journal-title":"J Clin Microbiol"},{"key":"4684_CR29","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/jeu.12069","volume":"60","author":"Y Qvarnstrom","year":"2013","unstructured":"Qvarnstrom Y, Nerad TA, Visvesvara GS (2013) Characterization of a new pathogenic Acanthamoeba species, A. byersi n. sp., isolated from a human with fatal amoebic encephalitis. J Eukaryot Microbiol 60:626\u2013633. doi: 10.1111\/jeu.12069","journal-title":"J Eukaryot Microbiol"},{"key":"4684_CR30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5694\/j.1326-5377.1997.tb138785.x","volume":"167","author":"RP Reed","year":"1997","unstructured":"Reed RP, Cooke-Yarborough CM, Jaquiery AL, Grimwood K, Kemp AS, Su JC, Forsyth JRL (1997) Fatal granulomatous amoebic encephalitis caused by Balamuthia mandrillaris. Med J Aust 167:82\u201384","journal-title":"Med J Aust"},{"key":"4684_CR31","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1128\/JCM.34.2.385-388.1996","volume":"34","author":"FL Schuster","year":"1996","unstructured":"Schuster FL, Visvesvara GS (1996) Axenic growth and drug sensitivity studies of Balamuthia mandrillaris, an agent of amebic meningoencephalitis in humans and other animals. J Clin Microbiol 34:385\u2013388","journal-title":"J Clin Microbiol"},{"key":"4684_CR32","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1128\/JCM.41.7.3175-3180.2003","volume":"41","author":"FL Schuster","year":"2003","unstructured":"Schuster FL, Dunnebacke TH, Booton GC, Yagi S, Kohlmeier CK, Glaser C, Vugia D, Bakardjiev A, Azimi P, Maddux-Gonzalez M, Visvesvara GS (2003) Environmental isolation of Balamuthia mandrillaris associated with a case of amebic encephalitis. J Clin Microbiol 41:3175\u20133180","journal-title":"J Clin Microbiol"},{"key":"4684_CR33","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3201\/eid1008.040139","volume":"10","author":"FL Schuster","year":"2004","unstructured":"Schuster FL, Glaser C, Honarmand S, Maguire JH, Visvesvara GS (2004) Balamuthia amebic encephalitis risk, Hispanic Americans. Emerg Infect Dis 10:1510\u20131512","journal-title":"Emerg Infect Dis"},{"key":"4684_CR34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1550-7408.2005.00082.x","volume":"53","author":"FL Schuster","year":"2006","unstructured":"Schuster FL, Guglielmo BJ, Visvesvara GS (2006a) In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amoebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. J Eukaryot Microbiol 53:121\u2013126","journal-title":"J Eukaryot Microbiol"},{"key":"4684_CR35","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1086\/503037","volume":"42","author":"FL Schuster","year":"2006","unstructured":"Schuster FL, Honarmand S, Visvesvara GS, Glaser CA (2006b) Detection of antibodies against free-living amoebae Balamuthia mandrillaris and Acanthamoeba species in a population of patients with encephalitis. Clin Infect Dis 42:1260\u20131265","journal-title":"Clin Infect Dis"},{"key":"4684_CR36","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1086\/597260","volume":"7","author":"FL Schuster","year":"2009","unstructured":"Schuster FL, Yagi S, Gavali S, Michelson D, Raghavan R, Blomquist I, Glastonbury C, AW B e, Scharnhorst D, Reed SL, Kuriyama S, Visvesvara GS, Glaser CA (2009) Under the radar: Balamuthia amebic encephalitis. Clin Infect Dis 7:879\u2013887. doi: 10.1086\/597260","journal-title":"Clin Infect Dis"},{"key":"4684_CR37","unstructured":"U.S. Food and Drug Administration (2014) Impavido (Miltefosine). Drugs@FDA\u2014FDA approved drug products. http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.DrugDetails . Accessed 27 March 2015"},{"key":"4684_CR38","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1128\/JCM.28.12.2750-2756.1990","volume":"28","author":"GS Visvesvara","year":"1990","unstructured":"Visvesvara GS, Martinez AJ, Schuster FL, Leitch GJ, Wallace SV, Sawyer TK, Anderson M (1990) Leptomyxid ameba, a new agent of amebic meningoencephalitis in humans and animals. J Clin Microbiol 28:2750\u20132756","journal-title":"J Clin Microbiol"},{"key":"4684_CR39","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1550-7408.1993.tb04943.x","volume":"40","author":"GS Visvesvara","year":"1993","unstructured":"Visvesvara GS, Schuster FL, Martinez AJ (1993) Balamuthia mandrillaris, N. G., N. Sp., agent of amebic meningoencephalitis in humans and animals. J Eukaryot Microbiol 40:504\u2013514","journal-title":"J Eukaryot Microbiol"},{"key":"4684_CR40","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/B978-0-7020-3935-5.00101-4","volume-title":"Tropical infectious diseases\u2014principles, pathogens, & practice","author":"GS Visvesvara","year":"2011","unstructured":"Visvesvara GS, Roy S, Maguire JH (2011) Pathogenic and opportunistic free-living amebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia pedata. In: Guerrant RL, Walker DH, Weller PF (eds) Tropical infectious diseases\u2014principles, pathogens, & practice, 3rd edn. Elsevier, Churchill Livingstone, Philadelphia, pp 707\u2013713","edition":"3"},{"key":"4684_CR41","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.4049\/jimmunol.0803859","volume":"182","author":"P Wadhone","year":"2009","unstructured":"Wadhone P, Maiti M, Agarwal R, Kamat V, Martin S, Saha B (2009) Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response. J Immunol 182:7146\u20137154. doi: 10.4049\/jimmunol.0803859","journal-title":"J Immunol"},{"key":"4684_CR42","unstructured":"World Health Organization (2011) Miltefosine (Inclusion)\u2014adults and children. 18th expert committee on the selection and use of essential medicines. World Health Organization. http:\/\/www.who.int\/selection_medicines\/committees\/expert\/18\/applications\/miltefosine\/en\/ . Accessed 27 March 2015"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-015-4684-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-015-4684-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-015-4684-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T04:56:29Z","timestamp":1653108989000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-015-4684-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["4684"],"URL":"https:\/\/doi.org\/10.1007\/s00436-015-4684-8","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,2]]}}}